NCT00173875View on ClinicalTrials.gov

Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

July 31, 2007

Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG

Iressa

Trial Locations (1)

Unknown

Department of Oncology, National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT00173875 - Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter